![Timothy D. Ocain](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy D. Ocain
Keine laufenden Positionen mehr
Profil
Timothy D.
Ocain worked as Vice President-Inflammation Discovery at Millennium Pharmaceuticals, Inc. from 1998 to 2006.
He then worked as Senior VP-New Product Strategy & Development at Enanta Pharmaceuticals, Inc. before becoming Senior Vice President-Research & Development at Seaside Therapeutics LLC from 2006 to 2009.
Ocain holds a doctorate degree from the University of Wisconsin and an undergraduate degree from the University of Wisconsin-Eau Claire.
Ehemalige bekannte Positionen von Timothy D. Ocain
| Unternehmen | Position | Ende |
|---|---|---|
Seaside Therapeutics LLC
 Seaside Therapeutics LLC Medical DistributorsDistribution Services Develops drug treatments to correct or improve the course of fragile x syndrome | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2009 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01.01.2006 |
| ENANTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Timothy D. Ocain
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
86
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enanta Pharmaceuticals, Inc.
 Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
Seaside Therapeutics LLC
Seaside Therapeutics LLC Medical DistributorsDistribution Services Develops drug treatments to correct or improve the course of fragile x syndrome | Distribution Services |
University of Wisconsin-Eau Claire
 University of Wisconsin-Eau Claire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
